RA
OCDX

Ramius Advisors’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Ramius Advisors’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-315,712
Closed -$5.89M – 345
2022
Q1 		$5.89M Buy
315,712
+286,557
+983% +$5.16M 2.69% 11
2021
Q4 		$624K Buy
+29,155
New +$574K 0.22% 71

Other funds holding OCDX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Ramius Advisors's OCDX Position: Q2 2022 in Review

Ramius Advisors sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 315,712 shares — an estimated $5.89M sold.

Ramius Advisors first reported a position in OCDX in Q4 2021 and held it in 2 quarters. The position peaked at $5.89M in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Ramius Advisors reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Ramius Advisors sold 315,712 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $5.89M.
  • Ramius Advisors first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q4 2021 and held it in 2 quarters.
  • Ramius Advisors's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $5.89M in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Ramius Advisors's 13F filing for Q2 2022, filed 9 Aug 2022.